1. Stocks
  2. Aarti Drugs Ltd.
  3. Swot
Aarti Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Stocks where Mutual Funds Increased Holdings in Past Month
Consistent Highest Return Stocks over Five Years - Nifty500
Effectively using its capital to generate profit - RoCE improving in last 2 years -16.8% returns for Nifty 500 over 1.9 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company with Low Debt
Annual Net Profits improving for last 2 years
Company with Zero Promoter Pledge
MFs increased their shareholding last quarter
Companies with growing costs YoY for long term projects
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score 86.4% returns for Nifty 500 over 4.5 years
Decline in Net Profit with falling Profit Margin (QoQ)
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
Declining profits every quarter for the past 4 quarters
Promoter decreasing their shareholding
Declining Net Cash Flow : Companies not able to generate net cash
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV
Rising Delivery Percentage Compared to Prev Day
Stocks with Expensive Valuations according to the Trendlyne Valuation Score 177.2% returns for Nifty 500 over 4.5 years
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Red Flag: Companies seeing significant coronavirus impact
Individual Superstar Investors raised stake in these stocks
Expensive Performers (DVM) 102.3% returns for over 5.4 years
Expensive Performers (DVM) 79.4% returns for over 5.4 years
Top Gainers